(Q36275435)

13 August 2017

1 reference

title

Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background (English)

1 reference

familial hypercholesterolemia

13 August 2017

0 references

1 reference

1 reference

based on heuristic

inferred from title

author name string

Despoina M Choumerianou

series ordinal

1

1 reference

13 August 2017

George V Z Dedoussis

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

43

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

793-801

1 reference

Comparison of statins in hypertriglyceridemia

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Use of antipeptide antibodies to demonstrate external orientation of the NH2-terminus of the low density lipoprotein receptor in the plasma membrane of fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

The UMD-LDLR database: additions to the software and 490 new entries to the database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.134

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.134

1 reference

13 August 2017

1 reference